Recent Finacing
Recent Raise
Stealth BioTherapeutics develops mitochondrial-targeted therapeutics, advancing elamipretide through late-stage clinical trials for mitochondrial diseases and dry AMD while progressing additional IND-enabling programs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Stealth BioTherapeutics.
